We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Induced Labor No Costlier than Spontaneous Labor

By HospiMedica International staff writers
Posted on 22 May 2019
A new study calculates that inducing labor at 39 weeks costs healthcare systems the same as waiting for spontaneous labor.

Researchers at the University of Utah (Salt Lake City, USA) and Intermountain Medical Center (IMC; Salt Lake City, UT, USA) conducted a multicenter study in the state of Utah involving 1,230 low-risk, nulliparous mothers, in order to measure actual cost differences to healthcare facilities between inducing labor one week early and waiting for spontaneous, natural labor. More...
Among study participants, 608 women were induced at 39 weeks and 622 experienced spontaneous labor.

The results of the study confirmed that contrary to common belief, the increased cost accrued from women spending more time in the hospital after inducing labor is offset by cost saved from avoiding additional tests, visits and medications later in pregnancy, as well as serious health outcomes, such as preeclampsia. In addition, the researchers found that inducing labor at 39 weeks reduced the rate of Cesarean section in new mothers. The study was presented at the annual meeting of the American College of Obstetricians and Gynecologists (ACPG), held during May 2019 in Nashville (TN, USA).

“We watched real patients as they went through the system to evaluate the actual costs for randomized patients for clinical outcomes. We found that the increase in cost from other parts of patient care cancel out those costs,” said lead author and study presenter Brett Einerson, MD, MPH, of the University of Utah. “This is a conclusion that is totally opposite of what we in obstetrics have assumed over the past 30 years. While the study is focused on Utah hospitals, the results are applicable across the country.”

“These results demonstrate the importance of considering cost in the medical decisions that we make,” said study co-author maternal fetal medicine physician Sean Esplin, MD, of Intermountain Healthcare. “This is a unique study that could only be accomplished in Utah. Intermountain Healthcare and the University of Utah are interested in providing the highest quality of care at the lowest price possible, so we are constantly tracking costs, which makes a study like this possible."

Related Links:
University of Utah
Intermountain Medical Center


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Tracheostomy Tube
Portex BLUselect
New
12-Lead Electrocardiograph
ASPEL ECG GREY v.07.325
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.